Overall Technical outlook

Price Summary

On 2025-08-13, NATCO Pharma Limited's stock opened at 888.1, reached a high of 907.65, dropped to a low of 887.1, and closed higher 1.82% at 904.25, with a trading volume of 516819 shares.
The peak price for the stock in the past 52 weeks is 1592.85, with the lowest price being 746.5.
The expected price range is between 710.0 and 1480.0, with a mean anticipated price of 997.9091, according to 11 analysts.

Technicals

Support and Resistance: The price for NATCOPHARM at 904.25 finds support at 902.85 and resistance at 973.6. This suggests a trading range, where 902.85 serves as a support level and 973.6 acts as a resistance point, potentially capping further gains.
NATCOPHARM supportResistance f25c93
Support/Resistance for NATCOPHARM


Aroon: The current state of the AROON is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
NATCOPHARM aroon f25c93
Aroon chart for NATCO Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral for NATCOPHARM, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
NATCOPHARM bbands f25c93
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR for NATCOPHARM remains bearish, establishing a key resistance level that could hinder upward movement. This ongoing bearish outlook suggests that the market may face challenges in breaking higher, with the resistance level acting as a barrier to potential gains.
NATCOPHARM psar f25c93
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: With the K-line positioned above the D-line and under 20 on the stochastic indicator, the market may be entering a bullish phase. This pattern indicates that the market could be preparing for an upward trend, emerging from a lower level. Investors might interpret this as a signal of potential growth for NATCO Pharma Limited.
NATCOPHARM stoch f25c93
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
NATCOPHARM trippleSMA f25c93
Tripple SMA chart for NATCO Pharma Limited


To accurately interpret a company's technical data, it is important to first examine its fundamentals. These include financial performance, management quality, and growth prospects. In addition, understanding the dynamics of the industry in which the company operates—such as competition, market trends, and regulatory factors—provides further insights. This combined analysis helps create a fuller picture, allowing for more precise conclusions to be drawn from the company's technical performance and stock behavior.